Latest for Progressive Supranuclear Palsy
See all trialsThe week in rare diseaseEach date is the day a change was posted. Open an item to see where things stand now.
- Trial sites3 new sites opened for Progressive Supranuclear Palsy Clinical Trial Platform (Phase 2, Adam Boxer)ClinicalTrials.gov
More about Progressive Supranuclear Palsy
The characteristic Richardson syndrome includes vertical gaze palsy, dystonic features affecting the neck and trunk, and progressive dementia. Additional clinical variants exist including PSP-parkinsonism with prominent parkinsonian features and PSP-cerebellar forms with predominant ataxia.
Keep reading about Progressive Supranuclear Palsy
Progressive deterioration leads to severe disability, and most people live 5 to 9 years after symptoms begin (MedlinePlus Genetics), considerably shorter than typical Parkinson disease. Unlike Parkinson disease, patients characteristically show poor or absent response to dopaminergic therapy (levodopa), which is a key diagnostic clue. MRI may show characteristic midbrain atrophy on sagittal views and hummingbird sign (rostral midbrain atrophy). Most cases occur sporadically, though rare familial forms exist.
What are the symptoms of Progressive Supranuclear Palsy?
These are common symptoms of Progressive Supranuclear Palsy, and how strong they are varies from person to person.
- Downward gaze palsy (difficulty looking down)
- Postural instability and frequent falls
- Bradykinesia and rigidity
- Cognitive decline and apathy
- Pseudobulbar palsy with dysarthria
- Trouble swallowing (dysphagia)
Who gets Progressive Supranuclear Palsy?
Progressive supranuclear palsy usually begins in mid to late adulthood, most often in a person's 60s, with insidious onset and gradual progression (MedlinePlus Genetics).
The condition is slightly more common in males than females. Most cases are sporadic, meaning there is no family history, and rare familial cases caused by MAPT gene variants follow an autosomal dominant pattern. PSP shows no ethnic predilection and occurs worldwide.
Next steps: find trials you might fitsee what is being testedget help payingget alerts
Which new Progressive Supranuclear Palsy medicines are in trials?
Investigational medicines Trial Friend tracks for Progressive Supranuclear Palsy, with trial results, safety findings and where each one stands.
How to get help paying for Progressive Supranuclear Palsy treatment
Charity funds and drugmaker programs for Progressive Supranuclear Palsy, checked at the source.
- From a charity · CurePSPQuality of Life Respite Program fundOpen
Pays for: In-home respite care hours for caregivers.
The foundation says: “The Quality of Life Respite Program is now accepting applications on a rolling basis as of August 2025.”
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Progressive Supranuclear Palsy
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Progressive Supranuclear Palsy resources
Reputable organizations and medical references for learning more about Progressive Supranuclear Palsy, including disease registries, foundation resources, and clinical guidelines.